Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Intangibles (2016 - 2019)

Aptevo Therapeutics' Intangibles history spans 4 years, with the latest figure at $4.6 million for Q3 2019.

  • For Q3 2019, Intangibles fell 15.21% year-over-year to $4.6 million; the TTM value through Sep 2019 reached $4.6 million, down 15.21%, while the annual FY2018 figure was $5.2 million, 13.65% down from the prior year.
  • Intangibles for Q3 2019 was $4.6 million at Aptevo Therapeutics, down from $4.8 million in the prior quarter.
  • Across five years, Intangibles topped out at $14.0 million in Q1 2017 and bottomed at $4.6 million in Q3 2019.
  • The 4-year median for Intangibles is $5.8 million (2018), against an average of $7.0 million.
  • The largest annual shift saw Intangibles decreased 12.01% in 2017 before it crashed 58.09% in 2018.
  • A 4-year view of Intangibles shows it stood at $6.9 million in 2016, then fell by 12.01% to $6.1 million in 2017, then fell by 13.65% to $5.2 million in 2018, then dropped by 11.85% to $4.6 million in 2019.
  • Per Business Quant, the three most recent readings for APVO's Intangibles are $4.6 million (Q3 2019), $4.8 million (Q2 2019), and $5.0 million (Q1 2019).